Diagnos Laboratorium Utama Tbk. vs Kedoya Adyaraya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 27.5K 24h volume), while Kedoya Adyaraya Tbk. trades at Rp1,050 (market cap 976.16B, 2.1K 24h volume). The key difference: Kedoya Adyaraya Tbk. is far larger — about 3.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (27.5K versus 2.1K). Which is the better fit depends on your goals.
| DGNS | RSGK | |
|---|---|---|
Market Cap | 308B | 976.16B |
Volume | 27.5K | 2.1K |
Lot | 275 | 21 |
Turnover | 6.23M | 2.21M |
Average Price | 226.59 | 1,050 |
Value | 6.23M | 2.21M |
Indicative Equilibrium Price | 230 | 1,050 |
Indicative Equilibrium Volume | 110 | 900 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Kedoya Adyaraya Tbk (the Company) was established on June 11, 1990 based on Notarial Deed No. 104 of Darsono Purnomosidi, S.H., Notary in Jakarta. The Company started its commercial operations in 2011. PT Medikatama Sejahtera is the ultimate parent Company of the Company and its Subsidiaries.
Read more on RSGK →